• Je něco špatně v tomto záznamu ?

Deteriorating effect of fluvastatin on the cholestatic liver injury induced by bile duct ligation in rats

H. Lotková, P. Staňková, T. Roušar, O. Kučera, L. Kohoutek, S. Mičuda, E. Brčáková, G. Kolouchová, Z. Cervinková

. 2011 ; 30 (1) : 66-74.

Jazyk angličtina Země Slovensko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026996

Grantová podpora
NS9739 MZ0 CEP - Centrální evidence projektů

Antiinflammatory effect of statins mediated by the reduction of cytokine IL-6 in hepatocytes have been reported. Contrary to beneficial effect, statins can increase susceptibility to mitochondrial dysfunction. Extrahepatic biliary obstruction is associated with oxidative stress, pro-inflammatory response and hepatocyte mitochondrial dysfunction. The aim of our study was to verify the effect of fluvastatin on cholestatic liver injury. Cholestasis was induced in Wistar rats by bile duct ligation. Fluvastatin (1 or 5 mg/kg) was administered after surgery and then daily for 7 days. The dose of 5 mg/kg led to the deterioration of hepatocellular injury. Despite lower production of IL-6, decrease in GSH content, rise of TGFß and inhibition of respiratory complex I in mitochondria were determined. The mRNA expressions of canalicular transporter Mdr1b and basolateral transporter Mrp3 increased in cholestatic liver. Fluvastatin administration then led to the attenuation of this change. Analogously, mRNA expression of conjugative enzyme Ugt1a1 was diminished by fluvastatin administration to cholestatic rats. We can conclude that decrease in the antioxidative status and mitochondrial dysfunction could at least in part participate on the deteriorating effect of fluvastatin. Whether these processes can be a consequence of the alteration in metabolism and transport of potentially toxic substances remains to verify.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026996
003      
CZ-PrNML
005      
20160601083822.0
007      
ta
008      
120816s2011 xo f 000 0#eng||
009      
AR
024    7_
$a 10.4149/gpb_2011_01_66 $2 doi
035    __
$a (PubMed)21460414
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Lotková, Halka, $d 1967- $7 xx0076217 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic. lotko@lfhk.cuni.cz
245    10
$a Deteriorating effect of fluvastatin on the cholestatic liver injury induced by bile duct ligation in rats / $c H. Lotková, P. Staňková, T. Roušar, O. Kučera, L. Kohoutek, S. Mičuda, E. Brčáková, G. Kolouchová, Z. Cervinková
520    9_
$a Antiinflammatory effect of statins mediated by the reduction of cytokine IL-6 in hepatocytes have been reported. Contrary to beneficial effect, statins can increase susceptibility to mitochondrial dysfunction. Extrahepatic biliary obstruction is associated with oxidative stress, pro-inflammatory response and hepatocyte mitochondrial dysfunction. The aim of our study was to verify the effect of fluvastatin on cholestatic liver injury. Cholestasis was induced in Wistar rats by bile duct ligation. Fluvastatin (1 or 5 mg/kg) was administered after surgery and then daily for 7 days. The dose of 5 mg/kg led to the deterioration of hepatocellular injury. Despite lower production of IL-6, decrease in GSH content, rise of TGFß and inhibition of respiratory complex I in mitochondria were determined. The mRNA expressions of canalicular transporter Mdr1b and basolateral transporter Mrp3 increased in cholestatic liver. Fluvastatin administration then led to the attenuation of this change. Analogously, mRNA expression of conjugative enzyme Ugt1a1 was diminished by fluvastatin administration to cholestatic rats. We can conclude that decrease in the antioxidative status and mitochondrial dysfunction could at least in part participate on the deteriorating effect of fluvastatin. Whether these processes can be a consequence of the alteration in metabolism and transport of potentially toxic substances remains to verify.
650    _2
$a alanintransaminasa $x krev $x účinky léků $x metabolismus $7 D000410
650    _2
$a alkalická fosfatasa $x krev $x účinky léků $x metabolismus $7 D000469
650    _2
$a zvířata $7 D000818
650    _2
$a aspartátaminotransferasy $x krev $x účinky léků $x metabolismus $7 D001219
650    _2
$a bilirubin $x krev $x metabolismus $7 D001663
650    _2
$a intrahepatální cholestáza $x farmakoterapie $x metabolismus $7 D002780
650    _2
$a kyseliny mastné mononenasycené $x škodlivé účinky $7 D005229
650    _2
$a glukuronosyltransferasa $x účinky léků $x metabolismus $7 D014453
650    _2
$a glutathion $x účinky léků $x metabolismus $7 D005978
650    _2
$a statiny $x škodlivé účinky $7 D019161
650    _2
$a indoly $x škodlivé účinky $7 D007211
650    _2
$a interleukin-6 $x metabolismus $7 D015850
650    _2
$a ligace $7 D008026
650    _2
$a játra $x účinky léků $x patologie $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a messenger RNA $x účinky léků $x metabolismus $7 D012333
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a transformující růstový faktor beta $x účinky léků $x metabolismus $7 D016212
650    _2
$a gama-glutamyltransferasa $x krev $x účinky léků $x metabolismus $7 D005723
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Křiváková, Pavla, $d 1979- $7 stk2008428620 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic
700    1_
$a Roušar, Tomáš $7 ola2012695942 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic
700    1_
$a Kučera, Otto, $d 1977- $7 xx0041536 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic
700    1_
$a Kohoutek, Lukáš $7 xx0231356 $u Department of Surgery, Faculty of Health Studies, University of Pardubice, Průmyslová 395, 532 10 Pardubice, Czech Republic
700    1_
$a Mičuda, Stanislav, $d 1972- $7 jn20010309083 $u Department of Pharmacology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic
700    1_
$a Doleželová, Eva $7 xx0179807 $u Department of Pharmacology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic; Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
700    1_
$a Kolouchová, Gabriela $7 _BN005219 $u Department of Pharmacology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic
700    1_
$a Červinková, Zuzana, $d 1951- $7 nlk20020106444 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38 Hradec Králové, Czech Republic
773    0_
$w MED00001896 $t General physiology and biophysics $x 0231-5882 $g Roč. 30, č. 1 (2011), s. 66-74
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21460414 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160601083945 $b ABA008
999    __
$a ok $b bmc $g 949038 $s 784342
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 30 $c 1 $d 66-74 $i 0231-5882 $m General physiology and biophysics $n Gen Physiol Biophys $x MED00001896
GRA    __
$a NS9739 $p MZ0
LZP    __
$b NLK122 $a Pubmed-20120816/11/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...